Tential (325A.T) Shares Decline 8.29 % on Friday 23 Nov 2026
- Closing price: JPY 1,132
- Trading volume (last 24 h): JPY 2.4 bn
- Market capitalisation: JPY 28.6 bn
- Shares outstanding: 25.3 million
- 52‑week high: JPY 2,180 (10 May 2026)
- 52‑week low: JPY 1,081.67 (23 Mar 2026)
- Simple moving average (200 days): JPY 1,454.14
- Performance since month‑end: -39.9 %
The decline occurred during a 24‑hour period ending at 07:44 PM Central Europe on Friday 23 Nov 2026. The price fell to JPY 1,132 on major exchanges. No corporate announcement was linked to the move.
Saluda Medical (ASX‑listed) First‑Year Results
Saluda Medical reported strong performance in its first year on the Australian Securities Exchange:
- Revenue: Exceeded guidance, driven by increased physician adoption and implant numbers in the United States and overseas.
- Regulatory milestone: FDA approval of the CAP24 paddle lead, expanding the Evoke® System to surgical paddle‑lead procedures.
- Platform launch: Global rollout of the EVA™ automated programming platform, improving clinician workflow.
- Commercial strategy: Investment in sales force capacity and physician education to boost utilization within existing accounts.
- Financials: Improved gross margin and operating cash outcomes surpassing IPO expectations.
- Future focus: Expansion of physician adoption, product portfolio development, and penetration of new procedural channels.
Related Stock Movements (Last 24 Hours)
| Stock (Symbol) | % Change | Current Price (JPY) | Market Capitalisation (JPY) | P/E Ratio |
|---|---|---|---|---|
| Yamashin‑filter (6240.T) | –1.42 % | 482 | 33.8 bn | 20.52 |
| Tess (5074.T) | –3.51 % | 465 | 34.2 bn | 42.26 |
| Maruzen Chi (3159.T) | +1.09 % | 365 | 34.0 bn | 10.35 |
| Shimojima (7482.T) | +0.28 % | 1,443 | 33.6 bn | 10.01 |
| Yamada Consulting L (4792.T) | +0.11 % | 1,752 | 33.7 bn | 12.02 |
These figures represent the most recent trading activity and market metrics for each listed company.